Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
about
The diabetic lung--a new target organ?Inhaled insulin: overview of a novel route of insulin administration.Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes.Inhaled human insulin (Exubera): clinical profile and patient considerations.Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus.Diabetes therapy trials with inhaled insulin.Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Inhaled insulin: new technology, new possibilities.Inhaled insulin for controlling blood glucose in patients with diabetesManagement of hyperglycaemia in type 2 diabetes: the end of recurrent failure?Inhaled insulin (Exubera): Combining efficacy and convenience.First approved inhaled insulin therapy for diabetes mellitus.When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?Inhaled insulins.Insulin structure and function.Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: rationale and specific agents.The new diabetes inhalers: new tools for the clinician.Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetesInhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight.Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.Single-chain insulins as receptor agonists.Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens.Upper airway obstruction and craniofacial morphology.A novel option for prandial insulin therapy: inhaled insulin.Inhaled human insulin (Exubera(®)): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus.Can inhaled insulin be used for the treatment of diabetes mellitus?Will availability of inhaled human insulin (Exubera) improve management of type 2 diabetes? The design of the Real World trial.The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinicalSelection and education of patients for inhaled insulin.Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
P2860
Q27027639-AFE593A0-1690-4F08-840B-53AF05111EEFQ33715395-B3E6C641-D904-4DCB-86B6-90E292AFAC25Q33996818-0A180B53-61D0-4DD5-875A-EB346811AAA3Q36013146-24B18F3C-502D-4AEA-B1E8-BB6C607AA8A6Q36494600-879B77EF-E8DC-4FBA-A5B3-8F83D173F2CFQ36512554-19EF20B2-FD5D-4111-8B08-0B2AB5F1A028Q36519973-5BF8174F-2F0E-4BB2-8116-52B4587C4368Q36521909-3BB1EF1F-7C33-4943-B44C-C9E7029B7E91Q36596878-F49AC417-F624-4498-AE36-24FE1AC1DA23Q36678584-5A6109BF-C079-45F1-829E-8C5FFC53CBE0Q36679610-716256E0-FDB3-4851-8293-2B00770ECE20Q36690218-31C0572B-8E8D-495C-9807-0D5CF89D5703Q36742128-DB950792-801D-4327-9C4D-3BCE84D18B00Q36754100-1442AB39-0EA2-4203-A1B3-A554B9E0774AQ36780901-B2A14799-12E3-483B-BC4C-0ECC328ED7BEQ36793605-9C48C9ED-29C7-4777-B7B4-DB229BB84920Q36839907-64C359C1-1C26-45C4-9376-4B3064DA6C25Q36841961-761F8EE8-2567-4EF2-A2D9-938C98C08F3DQ36856384-1F33E0C3-4B92-4893-BDFF-058EF7C561E5Q36861081-B4B15892-A37D-4787-A10B-83DE6D152425Q36889912-2333D28E-4DAB-4A3F-BCA0-3090407FB7AEQ37069180-649FCC32-F17F-4050-A3C8-9CF7F139C8F7Q37176283-BB43AAB8-99C3-4B7C-89F4-30791E534D93Q37330074-9B29F24B-6FB5-4E8A-91AE-EFF094F78388Q37352977-9BE194A0-02C7-4E46-957F-889F6253D5A1Q38942445-9DB1296D-65D2-4E45-B3F8-D5D38C522156Q40138501-FA8B0273-C2C4-4CBC-B928-C6DFAB2F46B5Q42472493-D7C74E92-5C59-4C29-BFA6-8D4BE52D8936Q42940242-6A4B1DD9-D0AB-4E51-900D-05171169F39EQ46627676-07BF32F3-27D9-47FD-925B-F9D1B1059762Q47992362-7DEBFE7A-0E5D-41B4-A4B6-5F74BCB5560CQ51491998-1696E806-1E6E-491F-81E9-F513AA6D410E
P2860
Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
description
2005 nî lūn-bûn
@nan
2005 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Inhaled insulin improves glyce ...... randomized, controlled trial.
@en
Inhaled insulin improves glyce ...... randomized, controlled trial.
@nl
type
label
Inhaled insulin improves glyce ...... randomized, controlled trial.
@en
Inhaled insulin improves glyce ...... randomized, controlled trial.
@nl
prefLabel
Inhaled insulin improves glyce ...... randomized, controlled trial.
@en
Inhaled insulin improves glyce ...... randomized, controlled trial.
@nl
P2093
P50
P1476
Inhaled insulin improves glyce ...... randomized, controlled trial.
@en
P2093
C Keith Bowering
Liam J Murphy
Paul Moore
Rosa Hendler
Shu-Ping Lan
Stephen C Clement
P304
P356
10.7326/0003-4819-143-8-200510180-00005
P407
P577
2005-10-01T00:00:00Z